NexImmune (NASDAQ:NEXI – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 9.9% of NexImmune shares […]
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) and Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings. Insider and Institutional Ownership 1.1% of Oncolytics […]
StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a report released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Aeglea BioTherapeutics Stock Performance The stock has a market cap of $48.64 million, a PE ratio of -0.16 and a beta of 2.57. The company […]
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) Receives $20.00 Consensus PT from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]
StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Wells Fargo & Company increased their target price on shares of Aeglea BioTherapeutics from $8.75 to $12.50 and gave the stock an equal weight […]
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report)‘s stock had its “outperform” rating restated by Lifesci Capital in a research note issued to investors on Monday, PriceTargets.com reports. Separately, TD Cowen assumed coverage on Spyre Therapeutics in a report on Wednesday, November 29th. They issued an “outperform” rating for the company. Read Our Latest Report on […]
Analysts Set Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) PT at $20.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aeglea BioTherapeutics (NASDAQ:AGLE) Stock Price Crosses Below 50-Day Moving Average of $11.42 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.